Condensed Consolidated Statements of Net Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Revenue	$ 3,618	$ 3,907	$ 116,610	$ 76,020
Cost of sales	8,356	11,177	71,695	47,468
Gross profit (loss)	(4,738)	(7,270)	44,915	28,552
Operating expenses:
General and administrative	2,613,075	1,545,271	6,316,930	5,696,109
Operations, research and development	528,557	535,236	1,548,678	1,724,013
Sales and marketing	133,494	72,667	406,086	815,563
Total operating expenses	3,275,126	2,153,174	8,271,694	8,235,685
Total operating (loss)	(3,279,864)	(2,160,444)	(8,226,779)	(8,207,133)
Other income	2,631	36,379	688,483	64,497
Other expense	(3,504)	(5,822)	(6,752)	(9,393)
Gain (loss) on derivative instruments	(74,366,000)	7	(74,366,000)	1,375
Loss from continuing operations	(77,646,737)	(2,129,880)	(81,911,048)	(8,150,654)
Loss from discontinued operations	(5,106)	(964,810)	(254,130)	(2,344,140)
Net (loss)	$ (77,651,843)	$ (3,094,690)	$ (82,165,178)	$ (10,494,794)
Loss from continuing operations (in dollars per share)	$ (107.24)	$ (4.99)	$ (135.7)	$ (24.23)
Loss from discontinued operations (in dollars per share)	(0.01)	(2.27)	(0.42)	(6.97)
Net (loss) per common share, basic and diluted (in dollars per share)	$ (107.25)	$ (7.26)	$ (136.12)	$ (31.2)
Weighted average shares used in computation – basic and diluted (in shares)	723,998	426,423	603,605	336,423